Status:
COMPLETED
Patient Satisfaction and OHRQoL In Removable Versus Fixed Implant Prostheses
Lead Sponsor:
Iman Abd-ElWahab Radi, PhD
Conditions:
Completely Edentulous Patients
Eligibility:
MALE
40-70 years
Phase:
NA
Brief Summary
Objectives to evaluate the oral health-related quality of life and patient satisfaction in completely edentulous patients, when restored by maxillary and mandibular fixed (screw-retained) or removable...
Detailed Description
Interventions General operative procedures: Once the eligibility criteria were fulfilled in a patient, new complete maxillary and mandibular dentures were fabricated for this patient to allow for pr...
Eligibility Criteria
Inclusion
- Completely edentulous male patients with an age range from 40- 70 years.
- Patients with a HbA1c equal to or less than 7
- All patients should have normal maxillo-mandibular relationship (Angle class I).
- Patients should have maxillary and mandibular ridges at least 7mm in width and 13 mm in height in the interforaminal areas and in the esthetic zones (premolar to premolar regions), respectively. This accommodated a pre-planned implant size of 3.7mm x 10 or 11mm.
- The maxillary and mandibular ridges should be covered by keratinized attached mucosa at least 5mm in width.
- An interarch space between the edentulous maxillary and mandibular ridges should not be less than 22 mm to accommodate the planned maxillary and mandibular implant-supported prostheses. This was confirmed by mounted diagnostic casts.
- Patients who were cooperative and who were psychologically and mentally stable as revealed from the initial interview with the patients were considered eligible.
Exclusion
- Females were excluded on purpose to prevent failures associated with osteoporosis and to avoid gender variability which definitely affects the results of patient satisfaction and OHIP.
- 2\. Patients requiring hard or, soft tissue grafting of the proposed implant sites.
- 3\. Heavy smokers (more than 10 cigarettes / day) or patients with para-functional habits like clenching or bruxism were excluded. This was important to decrease the risk of implant failure.
- 4\. Patients with temporo-mandibular joint disorders were considered ineligible because of the expected occlusal disturbances.
- 5\. Patients with systemic disease that might contra-indicate implants placement or affect osseointegration e.g. uncontrolled diabetes.
- 6\. Patients who took chemo-or radiotherapy or any drug that might counter-affect the healing process or the quality of bone.
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 28 2019
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT04694209
Start Date
November 1 2017
End Date
August 28 2019
Last Update
March 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of dentistry
Cairo, Manial, Egypt, 12911